| O.1 | Approve Financial Statements and Statutory Reports
| For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports
| For |
| O.3 | Approve Allocation of Income and Dividends of EUR 0.90 per Share
| For |
| O.4 | Approve Auditors' Special Report on Related-Party Transactions
| For |
| O.5 | Ratify Appointment of Olivier Lecomte as Director
| For |
| O.6 | Elect Bernadette Danet-Chevallier - Non-Executive Director | For |
| O.7 | Elect Olivier Lecompte - Non-Executive Director | For |
| O.8 | Approve Amendment of Remuneration Policy for 2020 of Yves Le Masne, CEO
| Oppose |
| O.9 | Approve Amendment of Remuneration Policy for 2018 of Jean-Claude Brdenk, Vice-CEO Until 31 December 2020
| Oppose |
| O.10 | Approve Amendment of Remuneration Policy for 2019 of Jean-Claude Brdenk, Vice-CEO Until 31 December 2020
| Oppose |
| O.11 | Approve Amendment of Remuneration Policy for 2020 of Jean-Claude Brdenk, Vice-CEO Until 31 December 2020
| Oppose |
| O.12 | Approve Compensation Report of Corporate Officers
| Oppose |
| O.13 | Approve Compensation of Philippe Charrier, Chairman of the Board
| For |
| O.14 | Approve Compensation of Yves Le Masne, CEO
| Oppose |
| O.15 | Approve Compensation of Jean-Claude Brdenk, Vice-CEO Until 31 December 2020
| Oppose |
| O.16 | Approve Remuneration Policy of Directors
| For |
| O.17 | Approve Remuneration Policy of Chairman of the Board
| For |
| O.18 | Approve Remuneration Policy of the CEO | Oppose |
| O.19 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital
| Oppose |
| E.20 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| E.21 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 40 Million
| For |
| E.22 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 8,078,915
| Oppose |
| E.23 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 8,078,915
| Oppose |
| E.24 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 21-23 and 25
| Oppose |
| E.25 | Approve Issue of Shares Deviating from Price Fixing Conditions | Oppose |
| E.26 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| Oppose |
| E.27 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| E.28 | Ratify Amendments of Bylaws to Comply with Legal Changes
| For |
| E.29 | Amend Article 24 and 25 of Bylaws Re: General Meetings
| For |
| E.30 | Amend Articles of Bylaws to Comply with Legal Changes
| For |
| E.31 | Authorize Filing of Required Documents/Other Formalities
| For |
